HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianhua Li Selected Research

Purinergic P2X Receptors

4/2021Nerve growth factor in muscle afferent neurons of peripheral artery disease and autonomic function.
11/2016Purinergic P2X Receptors and Heightened Exercise Pressor Reflex in Peripheral Artery Disease.
1/2016Bradykinin Contributes to Sympathetic and Pressor Responses Evoked by Activation of Skeletal Muscle Afferents P2X in Heart Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jianhua Li Research Topics

Disease

39Inflammation (Inflammations)
01/2022 - 04/2003
39Infections
01/2022 - 10/2005
37Sepsis (Septicemia)
01/2022 - 01/2003
35Neoplasms (Cancer)
09/2022 - 12/2007
13Endotoxemia
04/2021 - 01/2003
11Ischemia
01/2021 - 04/2005
9Hepatocellular Carcinoma (Hepatoma)
01/2022 - 12/2002
7COVID-19
01/2022 - 08/2020
7Heart Failure
01/2021 - 02/2007
7Osteoporosis
01/2018 - 04/2009
6Acute Lung Injury
01/2022 - 01/2003
6Peripheral Arterial Disease
04/2021 - 04/2013
6Neoplasm Metastasis (Metastasis)
02/2021 - 09/2013
6Shock
10/2020 - 02/2014
6Stroke (Strokes)
03/2020 - 03/2015
6Myocardial Infarction
01/2020 - 02/2007
6Glioma (Gliomas)
09/2018 - 02/2012
6Acquired Immunodeficiency Syndrome (AIDS)
01/2014 - 12/2002
5Carcinogenesis
09/2022 - 02/2017
5Pneumonia (Pneumonitis)
01/2022 - 01/2004
5Atherosclerosis
11/2021 - 05/2011
5Hypoxia (Hypoxemia)
02/2021 - 10/2013
5Substance-Related Disorders (Drug Abuse)
03/2014 - 07/2010
4Thrombosis (Thrombus)
01/2022 - 01/2021
4Lung Injury
01/2022 - 01/2014
4Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2017
4Virus Diseases (Viral Diseases)
01/2021 - 12/2018
4Breast Neoplasms (Breast Cancer)
01/2021 - 12/2014
4Pain (Aches)
01/2021 - 04/2016
4Toxoplasmosis
03/2020 - 03/2012
4Necrosis
10/2017 - 01/2003
3Body Weight (Weight, Body)
01/2022 - 03/2012
3Hypertension (High Blood Pressure)
01/2022 - 05/2013
3Fibrosis (Cirrhosis)
12/2021 - 01/2019
3Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 01/2021
3Liver Diseases (Liver Disease)
11/2021 - 04/2014
3Hemorrhagic Fever with Renal Syndrome (HFRS)
10/2021 - 11/2019
3Ventricular Heart Septal Defects (Ventricular Septal Defect)
09/2021 - 06/2010
3Hyperglycemia
01/2021 - 10/2016
3Chronic Hepatitis B
01/2021 - 02/2014
3Lung Neoplasms (Lung Cancer)
01/2021 - 05/2015
3Wounds and Injuries (Trauma)
01/2021 - 11/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2020 - 12/2016
3Ischemic Stroke
03/2020 - 01/2017
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 02/2017

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
09/2022 - 04/2003
37HMGB1 Protein (HMG1)IBA
01/2022 - 01/2003
20CytokinesIBA
01/2022 - 01/2003
17Pharmaceutical PreparationsIBA
01/2022 - 12/2002
13Biomarkers (Surrogate Marker)IBA
09/2022 - 11/2007
12AntibodiesIBA
01/2022 - 01/2003
9MicroRNAs (MicroRNA)IBA
01/2021 - 12/2011
9EndotoxinsIBA
10/2018 - 04/2005
8Long Noncoding RNAIBA
01/2022 - 01/2017
8VaccinesIBA
01/2022 - 03/2012
8Messenger RNA (mRNA)IBA
01/2022 - 12/2016
8InflammasomesIBA
12/2021 - 08/2012
82-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
12/2014 - 12/2007
7Antiviral Agents (Antivirals)IBA
01/2021 - 06/2013
7DNA (Deoxyribonucleic Acid)IBA
12/2019 - 01/2004
6AntigensIBA
12/2021 - 04/2011
6Heroin (Diamorphine)IBA
04/2014 - 12/2007
5oxidized low density lipoproteinIBA
11/2021 - 01/2016
5Small Interfering RNA (siRNA)IBA
01/2021 - 07/2011
5Adenosine Triphosphate (ATP)IBA
01/2019 - 02/2007
5Methadone (Dolophine)FDA LinkGeneric
04/2014 - 07/2010
4Circular RNAIBA
01/2022 - 01/2019
4Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2022 - 08/2012
4Therapeutic UsesIBA
12/2021 - 04/2005
4Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 01/2018
4Phosphotransferases (Kinase)IBA
05/2021 - 12/2014
4ChemokinesIBA
01/2021 - 07/2009
4CaspasesIBA
11/2019 - 03/2016
4Anti-Bacterial Agents (Antibiotics)IBA
11/2017 - 01/2004
4Biological ProductsIBA
12/2016 - 12/2011
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 01/2004
4TeaIBA
12/2015 - 11/2007
3huoxue qianyangIBA
01/2022 - 12/2021
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 11/2007
3ethyl pyruvateIBA
12/2021 - 01/2014
3Interleukin-12 Subunit p40IBA
12/2021 - 01/2017
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2021 - 01/2019
3Flame Retardants (Fire Retardants)IBA
10/2021 - 11/2019
3EnzymesIBA
09/2021 - 01/2012
3Purinergic P2X ReceptorsIBA
04/2021 - 01/2016
3Nerve Growth Factor (NGF)IBA
04/2021 - 05/2009
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 02/2017
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 12/2014
3Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2021 - 06/2017
3Hormones (Hormone)IBA
01/2021 - 09/2012
3Transcription Factors (Transcription Factor)IBA
01/2021 - 05/2015
3Interleukin-12 (IL 12)IBA
03/2020 - 01/2017

Therapy/Procedure

29Therapeutics
07/2022 - 12/2002
15Ligation
04/2021 - 11/2004
9Punctures
04/2021 - 02/2006
4Micro-Electrical-Mechanical Systems
10/2020 - 04/2018
4Critical Care (Surgical Intensive Care)
09/2017 - 01/2004
3Resuscitation
01/2022 - 02/2014
3Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2021 - 06/2016
3Analgesia
01/2021 - 03/2013